What’s new in minimal residual disease (MRD) detection in myeloma?
MGUS and the role of the microenvironment in myeloma
New insight into the biology of multiple myeloma: from clonal evolution to new treatment options
Recognizing clonal hematopoiesis – diagnostic challenges and clinical relevance
Message to mantle cell lymphoma physicians and patients